# Stepan Co: Form 10-Q for the period ended Sep 30, 2011

- Company: [Stepan Co](/companies/scl.md) (CIK 94049)
- Form: 10-Q
- Filed: 2011-10-28
- Accepted by EDGAR: Oct 28, 2011, 15:47 ET
- Period: 2011-09-30
- Accession: 0001193125-11-286131
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/94049/000119312511286131/d239524d10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/94049/000119312511286131/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2011-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2011-07-01 to 2011-09-30 | $499.3m | us-gaap:SalesRevenueNet |
| Revenue | 9 months, 2011-01-01 to 2011-09-30 | $1.40bn | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months, 2011-07-01 to 2011-09-30 | $435.3m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months, 2011-01-01 to 2011-09-30 | $1.20bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2011-07-01 to 2011-09-30 | $64.1m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2011-01-01 to 2011-09-30 | $195.5m | us-gaap:GrossProfit |
| Operating income | 3 months, 2011-07-01 to 2011-09-30 | $33.4m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2011-01-01 to 2011-09-30 | $97.3m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2011-07-01 to 2011-09-30 | $2.3m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2011-01-01 to 2011-09-30 | $6.5m | us-gaap:InterestExpense |
| Income tax | 3 months, 2011-07-01 to 2011-09-30 | $9.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2011-01-01 to 2011-09-30 | $27.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2011-07-01 to 2011-09-30 | $19.2m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2011-01-01 to 2011-09-30 | $58.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2011-07-01 to 2011-09-30 | $1.70 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2011-01-01 to 2011-09-30 | $5.25 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2011-07-01 to 2011-09-30 | $1.83 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2011-01-01 to 2011-09-30 | $5.63 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2011-07-01 to 2011-09-30 | 11,248,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2011-01-01 to 2011-09-30 | 11,199,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2011-01-01 to 2011-09-30 | $12.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2011-01-01 to 2011-09-30 | $61.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2011-01-01 to 2011-09-30 | $8.5m | us-gaap:PaymentsOfDividends |
| Share repurchases | 9 months, 2011-01-01 to 2011-09-30 | $1.3m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2011-09-30 | $32.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2011-09-30 | $489.1m | us-gaap:AssetsCurrent |
| Total assets | at 2011-09-30 | $892.0m | us-gaap:Assets |
| Current liabilities | at 2011-09-30 | $249.3m | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2011-09-30 | $150.2m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2011-09-30 | $36.4m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2011-09-30 | $396.4m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 68,338 characters.

The following is management’s discussion and analysis of certain significant factors that have affected the Company’s financial condition and results of operations during the interim period included in the accompanying condensed consolidated financial statements.

Except for the historical statements contained in this report, the matters discussed in the following discussion and analysis include forward-looking statements that are subject to certain risks, uncertainties and assumptions. Such forward-looking statements are intended to be identified in this document by the words, “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “objective,” “outlook,” “plan,” “project,” “possible,” “potential,” “should” and similar expressions. Actual results may vary materially.

Forward-looking statements speak only as of the date they are made, and the Company does not undertake any obligation to update them to reflect changes that occur after that date. Factors that could cause actual results to differ materially include the items described in Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2010.

### Overview

The Company produces and sells intermediate chemicals that are used in a wide variety of applications worldwide. The overall business comprises three reportable segments:

- Surfactants – Surfactants, which accounted for 74 percent of consolidated net sales for the first three quarters of 2011, are principal ingredients in consumer and industrial cleaning products such as detergents for washing clothes, dishes, carpets, floors and walls, as well as shampoos, body washes, toothpastes and fabric softeners. Other applications include germicidal quaternary compounds, lubricating ingredients, emulsifiers (for spreading agricultural products), plastics and composites and biodiesel. Surfactants are manufactured at six North American sites (five in the U.S. and one in Canada), three European sites (United Kingdom, France and Germany), three Latin American sites (Mexico, Brazil and Colombia) and one Asian site (Philippines; the Company acquired controlling interest in Stepan Philippines Inc. (SPI) on July 19, 2010). Also in the third quarter of 2010, the Company purchased assets in Singapore and initiated the development of a methyl esters plant in that location. Commercial production of methyl esters at the Singapore plant is expected in the second quarter of 2012. The Company also holds a 50 percent ownership interest in a joint venture, TIORCO, LLC (TIORCO), that markets chemical solutions for increasing the production of crude oil and natural gas from existing fields. The joint venture is accounted for under the equity method, and its financial results are excluded from surfactant segment operating results.
- Polymers – Polymers, which accounted for 23 percent of consolidated net sales for the first three quarters of 2011, include two primary product lines: polyols and phthalic anhydride. Polyols are used in the manufacture of rigid laminate insulation board for thermal insulation in the construction industry. Polyols are also a base raw material for flexible foams, coatings, adhesives, sealants and elastomers. Phthalic anhydride is used in unsaturated polyester resins, alkyd resins and plasticizers for applications in construction materials and components of automotive, boating and other consumer products. In addition, phthalic anhydride is used internally in the production of polyols. In the U.S.,

polymer product lines are manufactured at the Company’s Millsdale, Illinois, site. In Europe, polyols are manufactured at the Company’s subsidiaries in Germany and Poland. The Poland entity was acquired in the third quarter of 2010. Polyols are also produced at the Company’s 80-percent owned joint venture in Nanjing, China.

- Specialty Products – Specialty products, which accounted for three percent of consolidated net sales for the first three quarters of 2011, include flavors, emulsifiers and solubilizers used in the food and pharmaceutical industries. Specialty products are primarily manufactured at the Company’s Maywood, New Jersey, site. On June 23, 2011, the Company purchased three product lines from Lipid Nutrition B.V. (Lipid Nutrition), a part of Loders Croklaan B.V. See the ‘2011 Acquisition’ section that follows for details of the transaction.

All three segments have growth strategies that require investment outside of North America. Recent global initiatives include surfactant investments in Brazil and Singapore, polymer investments in Germany and Poland and specialty products investment in the Netherlands (Lipid Nutrition). These growth activities will result in higher near-term costs while facilitating the Company’s long-term growth strategies.

#### 2011 Acquisition

On June 23, 2011, the Company purchased the Clarinol®, Marinol®, and PinnoThin® product lines of Lipid Nutrition. The acquired product lines are included with the Company’s food and health services products in the specialty products segment, and provide a unique portfolio of nutritional fats for the food, supplement and nutrition industries. The acquired product lines are produced at the Company’s Maywood, New Jersey, plant and outside contract manufacturers. The purchase price of the acquisition was cash of $13.6 million, including $5.0 million of inventory.

#### 2010 Acquisitions

On July 2, 2010, the Company purchased the manufacturing assets of Peter Cremer GmbH’s 100,000 ton per year methyl esters plant located on Jurong Island in Singapore. The Company is installing methyl esters fractionation capability on the site. Methyl esters are a core building block of the Company’s surfactants segment, and the acquisition of the Jurong Island manufacturing assets provides the Company an opportunity to reach its global customer base with methyl esters and value added derivatives made from tropical oils available in the region. The Company plans for the site to begin methyl esters production in the second quarter of 2012. The purchase price of the manufacturing assets was $10.4 million.

On July 15, 2010, the Company’s Stepan Europe subsidiary acquired all the shares of Alfa Systems Sp. z o.o. The purchase included a polyol plant and related manufacturing assets in Brzeg Dolny, Poland. The acquisition provides the Company’s polymer segment with production capability in Eastern Europe and the ability to economically and effectively serve customers in Central and Eastern Europe. The Company recognized $10.1 million as the purchase price for Alfa Systems, comprised of $8.5 million of cash and $1.6 million in contingent consideration.

On July 19, 2010, the Company acquired controlling interest of SPI, raising the Company’s ownership interest in the entity from 50 percent to 88.8 percent. The Company paid $3.7 million of cash to acquire the interests of one owner, transferred $2.0 million of cash to SPI as an additional capital investment and capitalized a $3.9 million liability originally due the Company pursuant to a royalty agreement between the Company and SPI. The Company also guaranteed approximately $8.7 million of debt owed by SPI to a related party of the selling partner.

#### Deferred Compensation Plans

The accounting for the Company’s deferred compensation plans can cause period-to-period fluctuations in Company profits. Compensation expense results when the values of Company common stock and mutual funds held for the plans increase, and compensation income results when the values of Company common stock and mutual funds held for the plans decrease. The pretax effect of all deferred compensation-related activities (including realized and unrealized gains and losses on the mutual fund assets held to fund the deferred compensation obligations) for the three and nine months ended September 30, 2011 and 2010, and the income statement line items in which the effects of the activities were recorded are displayed in the following tables:

*(In millions)*

|  | Income (Expense) For the Three Months Ended September 30 2011 | 2010 | Change |
| --- | ---: | ---: | ---: |
| Deferred Compensation (Administrative expense) | $2.0 | $1.4 | $0.6 (1) |
| Realized/Unrealized Gains (Losses) on Investments (Other, net) | (1.1) | 1.0 | (2.1) |
| Pretax Income Effect | $0.9 | $2.4 | $(1.5) |

*(In millions)*

|  | Income (Expense) For the Nine Months Ended September 30 2011 | 2010 | Change |
| --- | ---: | ---: | ---: |
| Deferred Compensation (Administrative expense) | $2.7 | $0.5 | $2.2 (1) |
| Realized/Unrealized Gains (Losses) on Investments (Other, net) | (0.7) | 0.6 | (1.3) |
| Pretax Income Effect | $2.0 | $1.1 | $0.9 |

(1) See the applicable Corporate Expenses section of this management’s discussion and analysis for details regarding the period-to-period change in deferred compensation.

#### Effects of Foreign Currency Translation

The Company’s foreign subsidiaries transact business and report financial results in their respective local currencies. As a result, foreign subsidiary income statements are translated into U.S. dollars at average foreign exchange rates appropriate for the reporting period. Because foreign exchange rates fluctuate against the U.S. dollar over time, foreign currency translation affects period-to-period comparisons of financial statement items (i.e., because foreign exchange rates fluctuate, similar period-to-period local currency results for a foreign subsidiary may translate into different U.S. dollar results). For the three and nine month periods ended September 30, 2011, the U.S. dollar weakened against all the foreign currencies in the locations where the Company does business, when compared to the exchange rates for the respective three and nine month periods ended September 30, 2010. Consequently, reported net sales, expense and income amounts for the three and nine month periods ended September 30, 2011, were higher than they would have been had the foreign currency exchange rates remained constant with the rates for the same periods 2010. The following table presents the effect that foreign currency translation had on the quarter-over-quarter and year-over-year changes in consolidated net sales and various income line items for the three and nine months ended September 30, 2011:

*(In millions)*

|  | Three Months Ended September 30 2011 | 2010 | Increase (Decrease) | Increase Due to Foreign Translation |
| --- | ---: | ---: | ---: | ---: |
| Net Sales | $499.3 | $366.8 | $132.5 | $12.4 |
| Gross Profit | 64.1 | 58.4 | 5.7 | 1.0 |
| Operating Income | 33.4 | 31.1 | 2.3 | 0.4 |
| Pretax Income | 28.2 | 31.3 | (3.1) | 0.4 |

*(In millions)*

|  | Nine Months Ended September 30 2011 | 2010 | Increase (Decrease) | Increase Due to Foreign Translation |
| --- | ---: | ---: | ---: | ---: |
| Net Sales | $1,398.9 | $1,070.3 | $328.6 | $32.5 |
| Gross Profit | 195.5 | 185.5 | 10.0 | 2.9 |
| Operating Income | 97.3 | 94.6 | 2.7 | 1.3 |
| Pretax Income | 86.7 | 89.3 | (2.6) | 1.1 |

30

RESULTS OF OPERATIONS

#### Three Months Ended September 30, 2011 and 2010

### Summary

Net income attributable to the Company for the third quarter of 2011 was $19.2 million, which was essentially unchanged from net income reported for the third quarter of last year. Diluted earnings per share were $1.70 for the third quarter of 2011 compared to $1.73 for the third quarter of 2010. Following this summary is a detailed discussion of segment operating performance for the third quarter of 2011.

Consolidated net sales increased $132.5 million, or 36 percent, quarter over quarter. Higher average selling prices, a four percent increase in sales volume and the effects of foreign currency translation accounted for approximately $105.1 million, $15.0 million and $12.4 million, respectively, of the increase. The rise in average selling prices was primarily attributable to price increases resulting from higher quarter-over-quarter raw material costs. A more favorable sales mix also contributed. Sales volume grew for all three reportable segments. The foreign currency translation effect reflected the weakening of the U.S. dollar against all foreign currencies in which the Company transacts business.

Operating income for the third quarter of 2011 increased $2.3 million, or seven percent, over operating income reported in the same quarter of last year. Gross profit increased $5.7 million, or 10 percent, as all three segments posted improvements, primarily as a result of improved margins coupled with higher sales volume. The effects of foreign currency translation contributed $1.0 million to the quarter-over-quarter gross profit change.

Operating expenses increased $3.4 million, or 12 percent, between comparative quarters due primarily to the following:

- Investment for future growth opportunities in Singapore, Brazil, Poland, the Netherlands and the Philippines increased total operating expenses by $2.1 million quarter-over-quarter.
- Marketing expenses increased $1.5 million, or 16 percent, quarter over quarter. Incremental expenses related to marketing the product lines acquired in the Lipid Nutrition acquisition (completed in the second quarter of 2011) and increased expenses to support the expanding Asia organization accounted for $1.0 million (approximately $0.5 million each) of the increase. Higher salaried payroll and travel-related expenses and the effects of foreign currency translation also contributed.
- Administrative expenses increased $1.2 million, or 14 percent, due to a $1.0 million increase in legal and environmental expenses, $0.4 million of additional expenses for the continuing development of business in Singapore and $0.3 million of expense related to the new Lipid Nutrition business. The increase in legal and environmental expenses reflected favorable remediation liability adjustments made in 2010 for two sites. A $0.6 million increase in deferred compensation income partially offset the foregoing items. See the ‘Overview’ and ‘Corporate Expenses’ sections of this management discussion and analysis for details regarding deferred compensation.
- Research, development and technical service expenses were up $0.7 million, or seven percent, quarter over quarter. Increased staffing and salary expense accounted for most of the increase.

Interest expense, net for the third quarter of 2011 was up $0.3 million, or 13 percent, over interest expense for the same quarter of 2010. Higher average debt levels led to the increase. The increase in the average debt levels were primarily attributable to an approximate $96.0 million increase in year-to-date working capital requirements precipitated by inflation in raw material costs. A seller-financed equipment purchase arrangement transacted in the fourth quarter of 2010 contributed to the increase in the average debt level.

The loss from equity joint ventures increased $1.0 million between quarters. The equity loss included results for TIORCO for the third quarter of 2011 compared to results for TIORCO and SPI for the third quarter of 2010 (the 2010 amount included a partial quarter of SPI). The prior year results included a $0.7 million gain related to the revaluation of the Company’s original 50 percent interest in SPI as part of the third quarter 2010 acquisition of controlling interest in the entity. The TIORCO joint venture is primarily a cost sharing venture with Nalco Company, as the Company sells surfactants directly into the enhanced recovery market and the corresponding profit resides in the surfactants segment operating results. As planned, the equity loss in TIORCO increased $0.2 million quarter over quarter.

Other, net was $2.0 million of expense for the third quarter of 2011 compared to $2.0 million of income for the same quarter of 2010, an unfavorable swing of $4.0 million. The Company reported $1.3 million of unrealized and realized losses on its deferred compensation mutual fund investment assets in this year’s third quarter versus $1.0 million of gains in the third quarter of last year. The Company reported foreign exchange losses of $0.8 million in the third quarter of 2011 compared to $1.0 million of gains in the third quarter of 2010.

The effective tax rate was 31.9 percent for the third quarter of 2011 compared to 38.5 percent for the third quarter of 2010. The decrease was primarily attributable to a non-recurring provision in the prior year related to the purchase of an increased ownership in SPI. Also contributing to the decrease was the implementation of a holding company structure that will provide a recurring benefit in lowering the effective tax rate on foreign earnings.

### Segment Results

*(In thousands)*

| For the three months ended September 30, 2011 | Surfactants | Polymers | Specialty Products | Segment Results | Corporate | Total |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Net sales | $361,874 | $120,061 | $17,400 | $499,335 | — | $499,335 |
| Operating income | 23,191 | 12,165 | 3,557 | 38,913 | (5,510) | 33,403 |
| For the three months ended September 30, 2010 |  |  |  |  |  |  |
| Net sales | $264,104 | $91,805 | $10,891 | $366,800 | — | $366,800 |
| Operating income | 21,330 | 10,490 | 4,239 | 36,059 | (4,918) | 31,141 |

32

#### Surfactants

Surfactants net sales for the third quarter of 2011 increased $97.8 million, or 37 percent, over net sales for the same quarter of 2010. All regions contributed to the improvement. Higher average selling prices, the effects of foreign currency translation and a three percent increase in sales volume accounted for approximately $81.6 million, $8.9 million and $7.3 million, respectively, of the net sales growth. A quarter-over-quarter comparison of net sales by region follows:

*(In thousands)*

|  | For the Three Months Ended September 30, 2011 | September 30, 2010 | Increase | Percent Change |
| --- | ---: | ---: | ---: | --- |
| North America | $219,149 | $166,644 | $52,505 | +32 |
| Europe | 87,208 | 63,233 | 23,975 | +38 |
| Latin America | 40,442 | 30,744 | 9,698 | +32 |
| Asia | 15,075 | 3,483 | 11,592 | +333 |
| Total Surfactants Segment | $361,874 | $264,104 | $97,770 | +37 |

Net sales for North American operations increased 32 percent due to a 36 percent increase in average selling prices and the effects of foreign currency translation, which accounted for $57.3 million and $0.9 million, respectively, of the net sales change. A three percent decline in sales volume reduced the quarter-over-quarter increase by $5.7 million. The rise in average selling prices reflected higher quarter-over-quarter raw material costs. A more favorable sales mix of products also contributed to the increase in average selling prices. The foreign currency translation effect reflected the strengthening of the Canadian dollar against the U.S. dollar over the comparative periods. Lower demand for laundry and cleaning products led to the sales volume decline. Increased sales volume for biodiesel and oil field chemicals partially offset the lower laundry and cleaning sales.

Net sales for European operations increased 38 percent due to a 30 percent increase in average selling prices and the favorable effects of foreign currency translation, which accounted for $18.6 million and $5.7 million, respectively of the net sales increase. Sales volume declined one percent. The increase in average selling prices reflected higher quarter-over-quarter raw material costs. The foreign currency translation impact resulted from the strengthening of the European euro and British pound sterling against the U.S. dollar.

Net sales for Latin American operations were up 32 percent due to a 14 percent rise in average selling prices, a 10 percent growth in sales volume and the favorable effects of foreign currency translation, which accounted for $4.7 million, $3.0 million and $2.0 million, respectively, of the net sales improvement. The higher average selling prices reflected the Company’s continued efforts to recover increasing raw material costs. Additional neutralizer business for the Company’s Brazil subsidiary and increased fabric softener business for the Company’s Mexico subsidiary accounted for the quarter-over-quarter increase in sales volume. The favorable currency translation impact resulted from the strengthening of the currencies for all three Latin American locations against the U.S. dollar.

The $11.6 million increase in net sales for Asia operations reflected sales for the Company’s Philippines subsidiary. The Company first consolidated the Philippines joint venture in the third quarter of last year; therefore, 2010 net sales only included activity for a partial quarter.

Surfactants operating income for the third quarter of 2011 was up $1.9 million, or nine percent, over operating income for the third quarter of 2010. Gross profit increased $3.6 million, or nine percent, primarily due to improved margins in North America. The effects of foreign currency translation contributed $0.6 million of the quarter-over-quarter gross profit increase. Operating expenses increased $1.8 million, or 10 percent. Quarter-over-quarter comparisons of gross profit by region and total segment operating expenses and operating income follow:

*(In thousands)*

| Gross Profit | For the Three Months Ended September 30, 2011 | September 30, 2010 | Increase (Decrease) | Percent Change |
| --- | ---: | ---: | ---: | --- |
| North America | $33,451 | $28,548 | $4,903 | +17 |
| Europe | 4,976 | 6,554 | (1,578) | -24 |
| Latin America | 3,453 | 3,367 | 86 | +3 |
| Asia | 351 | 142 | 209 | +147 |
| Total Surfactants Segment | $42,231 | $38,611 | $3,620 | +9 |
| Operating Expenses | 19,040 | 17,281 | 1,759 | +10 |
| Operating Income | $23,191 | $21,330 | $1,861 | +9 |

North American gross profit increased 17 percent quarter over quarter despite a three percent decline in sales volume. The previously discussed increase in average selling prices, coupled with a more favorable mix of sales, more than offset the impact of the decrease in sales volume. In addition, prior year third quarter gross profit was negatively affected by expenses related to a one-month lockout of hourly workers at the Company’s Millsdale (Illinois) plant.

Gross profit for European operations declined 24 percent due largely to a less favorable product mix and the effects of a planned three-week mandatory inspection shutdown at the Company’s Germany subsidiary. The shutdown led higher quarter-over-quarter expenses (approximately $0.5 million) and lower production. The previously mentioned decline in sales volume also contributed to the reduction in gross profit.

Latin American gross profit grew three percent quarter over quarter due to increased sales volume and the favorable effects of foreign currency translation ($0.2 million). The sales volume growth was largely offset by increased raw material costs and lagging selling price increases, particularly for the Company’s Mexico subsidiary, as well as higher manufacturing costs, primarily attributable to increased overhead associated with the Brazil neutralizer expansion.

The gross profit increase for Asia operations was primarily attributable to a full quarter of financial activity recorded for the Company’s Philippines subsidiary in 2011 compared to a partial quarter for 2010.

Operating expenses for the surfactants segment increased $1.8 million, or 10 percent, quarter over quarter. Increased expenses in Asia ($0.5 million) for expanding the organization in that region, higher marketing expenses in North American operations ($0.5 million) and the effects of foreign currency translation ($0.4 million) accounted for most of the overall operating expense increase. The higher North American operations marketing expense was largely attributable to supporting the growing operations in Asia.

#### Polymers

Net sales for the third quarter of 2011 increased $28.3 million, or 31 percent, over net sales for the third quarter of last year. Higher average selling prices, a 10 percent improvement in sales volume and the favorable effects of foreign currency translation accounted for $15.8 million, $9.0 million and $3.5 million, respectively, of the increase. A quarter-over-quarter comparison of net sales by region is displayed below:

*(In thousands)*

|  | For the Three Months Ended September 30, 2011 | September 30, 2010 | Increase | Percent Change |
| --- | ---: | ---: | ---: | --- |
| North America | $73,013 | $57,986 | $15,027 | +26 |
| Europe | 39,312 | 28,228 | 11,084 | +39 |
| Asia and Other | 7,736 | 5,591 | 2,145 | +38 |
| Total Polymers Segment | $120,061 | $91,805 | $28,256 | +31 |

Net sales for North American operations increased 26 percent due to an 18 percent rise in average selling prices and a seven percent increase in sales volume, which accounted for $10.9 million and $4.1 million, respectively of the improvement in net sales. The higher average selling prices reflected rising raw material costs for all polymer product lines. Sales volume for polyols increased 17 percent primarily on improved rigid insulation board demand from existing customers. External sales volume for phthalic anhydride declined 8 percent due to a decrease in demand for polyester resins (which are used to manufacture materials for the automobile, construction, marine and recreational vehicle industries). Internal consumption of phthalic anhydride increased due to the higher sales volume of polyols.

Net sales for European operations increased 39 percent due primarily to a 14 percent rise in average selling prices and a 13 percent increase in sales volume, which accounted for $4.3 million and $3.7 million, respectively, of the net sales improvement. The favorable effects of foreign currency translation, resulting from a stronger European euro against the U.S. dollar, contributed $3.1 million to the quarter-over-quarter net sales increase. The increase in average selling prices was principally attributable to higher raw material costs. Sales volume grew 13 percent as demand for rigid foam insulation in replacement roofing on commercial buildings remained strong. Polyol demand also grew for metal panel insulation and adhesive applications. The Company’s Poland subsidiary accounted for 64 percent of the quarter-over-quarter sales volume growth.

Asia and Other operations’ net sales were up 38 percent quarter over quarter due to a 22 percent increase in sales volume, a seven percent increase in average selling prices and the effects of foreign currency translation, which accounted for $1.2 million, $0.5 million and $0.4 million, respectively, of the net sales improvement. New business for the Company’s China subsidiary led to the quarter-over-quarter growth in sales volume. Higher raw material costs drove the selling price increase.

Polymer operating income for the third quarter of 2011 increased $1.7 million, or 16 percent, over operating income for the same quarter of 2010. Gross profit grew $2.2 million, or 15 percent, as all three regions reported improved results. Operating expenses increased $0.6 million, or 12 percent, between quarters. Below are quarter-over-quarter comparisons of gross profit by region and total segment operating expenses and operating income:

*(In thousands)*

| Gross Profit | For the Three Months Ended September 30, 2011 | September 30, 2010 | Increase | Percent Change |
| --- | ---: | ---: | ---: | --- |
| North America | $12,630 | $11,705 | $925 | +8 |
| Europe | 3,813 | 3,029 | 784 | +26 |
| Asia and Other | 734 | 216 | 518 | +240 |
| Total Polymers Segment | $17,177 | $14,950 | $2,227 | +15 |
| Operating Expenses | 5,012 | 4,460 | 552 | +12 |
| Operating Income | $12,165 | $10,490 | $1,675 | +16 |

Gross profit for North American operations increased eight percent due to the seven percent growth in sales volume noted earlier. Selling price increases have kept pace with rising raw material costs.

Gross profit for European operations increased 26 percent quarter over quarter due to the 13 percent growth in sales volume and $0.4 million in favorable foreign currency translation impact. Polymer gross profit was adversely impacted by an estimated $1.8 million of higher costs of supplying polyols from the U.S. to Europe due to fire damage to one of the Company’s polyol reactors in Germany that occurred in the second quarter of this year. Repairs should be completed in November. Property insurance is expected to cover the repair costs. The potential benefit of any recovery under business interruption insurance will not be recorded until a settlement is recovered. Gross profit was also negatively affected by higher maintenance costs resulting from a planned shutdown at the Germany plant that is required every five years.

The increase in gross profit for Asia and Other operations reflected the 22 percent increase in sales volume.

The $0.6 million increase in operating expenses was principally attributable to higher expenses for European operations. Approximately $0.4 million of the increase was attributable to the inclusion of a full quarter of Poland subsidiary activity in the third quarter of 2011 compared to a partial quarter in 2010.

#### Specialty Products

Net sales for the third quarter of 2011 were $6.5 million, or 60 percent, higher than net sales for the third quarter of 2010. Sales related to the new product lines acquired in the second quarter 2011 Lipid Nutrition acquisition accounted for most of the segment’s increase in net sales. Operating income was down $0.7 million, or 16 percent, quarter over quarter due largely to higher raw material costs, particularly for food ingredient products for which competitive pressures have made it difficult to raise selling prices. Start-up costs related to the assimilation of the Lipid Nutrition product lines also contributed to the operating income decline.

#### Corporate Expenses

Corporate expenses, which comprise operating expenses that are not allocated to the reportable segments, increased $0.6 million (12 percent) to $5.5 million for the third quarter of 2011 from $4.9 million for the third quarter of 2010. Legal and environmental expenses increased $1.0 million and income related to the Company’s deferred compensation plans increased $0.6 million. The increase in legal and environmental expenses reflected favorable remediation liability adjustments made in 2010 for two sites that did not recur in 2011. With respect to deferred compensation, the Company recorded $2.0 million of income in the third quarter of 2011 compared to $1.4 million of income in the same quarter of 2010. Declines in the values of the mutual fund assets to which a portion of the deferred compensation obligations are tied led to the higher quarter-over-quarter deferred compensation income. The impact of the mutual fund performance was partially offset by the effect of Company common stock prices that declined less in the third quarter of 2011 than in 2010. The value of Company common stock declined $3.72 per share from $70.90 per share at June 30, 2011, to $67.18 per share at September 30, 2011. For last year’s third quarter, the Company’s common stock price decreased $9.32 per share from $68.43 per share at June 30, 2010, to $59.11 per share at September 30, 2010. The accounting treatment for the Company’s deferred compensation plans results in income when the value of Company common stock or mutual funds held in the plans falls and expense when the value of Company common stock or mutual funds increases.

#### Nine Months Ended September 30, 2011 and 2010

### Summary

Net income attributable to the Company for the first three quarters of 2011 increased three percent to $58.8 million, or $5.25 per diluted share, compared to $56.9 million, or $5.14 per diluted share, for the first three quarters of 2010. Following the summary is a detailed discussion of segment operating performance for the first three quarters of 2011 follows the summary.

Consolidated net sales increased $328.6 million, or 31 percent, between years. Higher average selling prices, the favorable effects of foreign currency translation and a three percent growth in sales volume accounted for approximately $268.0 million, $32.5 million and $28.1 million, respectively, of the increase. The rise in average selling prices was primarily attributable to price increases resulting from higher year-over-year raw material costs. The foreign currency translation effect reflected the weakening of the U.S. dollar against all foreign currencies in which the Company transacts business. Sales volume was up for all three reportable segments.

Operating income for the first three quarters of 2011 improved $2.8 million, or three percent, over operating income reported for the same period of 2010. Gross profit grew $10.0 million, or five percent, primarily on improved results for the surfactants and polymers segments, primarily North American operations. Increased raw material costs led to a decline in gross profit for the specialty products segment. The effects of foreign currency translation added $2.9 million to the year-over-year increase in gross profit.

Operating expenses increased $7.2 million, or eight percent, from year to year due primarily to the following:

- Investment for future growth opportunities in Singapore, Brazil, Poland, the Netherlands and the Philippines increased total operating expenses by $5.1 million year-over-year.
- Marketing expenses increased $4.2 million, or 14 percent, year over year. Expenses related to the Company’s growth initiatives in Singapore and Poland and the consolidation of the Philippines entity accounted for $1.9 million of the increase. U.S. travel-related expenses were up $0.7 million and first-time marketing expenses related to the product lines acquired in the Lipid Nutrition acquisition (completed in the second quarter of 2011) added $0.5 million. The effects of foreign currency translation contributed $0.7 million of the year-over-year change.
- Administrative expenses increased $1.4 million, or four percent, due to $1.6 million of added expenses related to the acquired entities that were not consolidated until the third quarter of 2010 and $1.2 million of higher legal and environmental expenses. The increase in legal and environmental expenses reflected favorable remediation liability adjustments made in 2010 for two sites. In addition to the foregoing, the effects of foreign currency translation and expenses related to the new Lipid Nutrition business contributed $0.6 and $0.3 million, respectively, to the increase. Higher deferred compensation income reduced the year-over-year increase in administrative expense by $2.2 million. See the ‘Overview’ and ‘Corporate Expenses’ sections of this management discussion and analysis for details regarding deferred compensation.
- Research, development and technical service expenses were up $1.6 million, or six percent. Higher U.S. staffing and salary expense accounted for $1.1 million of the increase. The effects of foreign currency translation also contributed.

Interest expense, net for the first three quarters of 2011 was up $1.7 million, or 37 percent, between years. Higher average borrowing levels led to the increase. The increase in the average debt levels were, in part, attributable to an approximate $96.0 million increase in year-to-date working capital requirements driven by inflation in raw material costs. In addition, in June 2010, the Company secured $40 million of additional long-term notes to take advantage of low interest rates and support global growth initiatives. The assumption of debt in the third quarter 2010 business acquisitions and a seller-financed equipment purchase arrangement transacted in the fourth quarter of 2010 contributed to the increased borrowing levels.

The loss from equity joint ventures, which included results for TIORCO for the first three quarters of 2011 and the results for TIORCO and SPI for the first three quarters of 2010 (the 2010 amount included SPI results for the first half of the year plus part of the third quarter), increased $1.5 million year over year. SPI’s equity income in the prior year was $1.2 million, which included a $0.7 million gain related to revaluing the Company’s original 50 percent interest in SPI as part of the third quarter 2010 acquisition of controlling interest in the entity. The TIORCO joint venture is primarily a cost sharing venture with Nalco Company, as the Company sells surfactants directly into the enhanced recovery market and the corresponding profit resides in the surfactants segment operating results. As planned, the equity loss in TIORCO increased $0.3 million year over year.

Other, net was $1.5 million of expense for the first three quarters of 2011 compared to $0.7 million of income for the same three quarters of 2010. Investment losses, attributable primarily to the Company’s deferred compensation mutual fund investments, amounted to $0.8 million for the first three quarters of 2011 compared to $0.6 million of gains for the same period last year. The Company reported foreign exchange losses of $0.7 million in the first three quarters of 2011 versus less than $0.1 million of gains in the same period of 2010.

The effective tax rate was 31.9 percent for the first three quarters of 2011 compared to 36.2 percent for the first three quarters of 2010. The decrease was primarily attributable a non-recurring provision in the prior year related to the purchase of an increased ownership in SPI. Also contributing to the decrease was the implementation of a holding company structure that will provide a recurring benefit in lowering the effective tax rate on foreign earnings.

### Segment Results

*(In thousands)*

| For the nine months ended September 30, 2011 | Surfactants | Polymers | Specialty Products | Segment Results | Corporate | Total |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Net sales | $1,030,526 | $327,314 | $41,082 | $1,398,922 | — | $1,398,922 |
| Operating income | 76,048 | 33,594 | 10,306 | 119,948 | (22,616) | 97,332 |
| For the nine months ended September 30, 2010 |  |  |  |  |  |  |
| Net sales | $790,984 | $245,808 | $33,542 | $1,070,334 | — | $1,070,334 |
| Operating income | 77,318 | 27,654 | 12,238 | 117,210 | (22,642) | 94,568 |

#### Surfactants

Surfactants net sales for the first three quarters of 2011 increased $239.5 million, or 30 percent, over net sales for the first three quarters of 2010. Higher average selling prices, the favorable effects of foreign currency translation and a one percent increase in sales volume accounted for approximately $208.1 million, $24.7 million and $6.7 million, respectively, of the net sales improvement. A year-over-year comparison of net sales by region follows:

*(In thousands)*

|  | For the Nine Months Ended September 30, 2011 | September 30, 2010 | Increase | Percent Change |
| --- | ---: | ---: | ---: | --- |
| North America | $641,947 | $524,485 | $117,462 | +22 |
| Europe | 244,107 | 181,291 | 62,816 | +35 |
| Latin America | 107,360 | 81,725 | 25,635 | +31 |
| Asia | 37,112 | 3,483 | 33,629 | NM |
| Total Surfactants Segment | $1,030,526 | $790,984 | $239,542 | +30 |

39

Net sales for North American operations increased 22 percent due to a 29 percent increase in average selling prices and the favorable effects of foreign currency translation, which accounted for $143.5 million and $2.9 million, respectively, of the net sales change. A six percent decline in sales volume reduced the year-over-year change by $28.9 million. Selling prices were increased year-over-year to recover the effects of higher raw material costs. In addition, a more favorable mix of sales contributed to the increase in average selling prices. The foreign currency translation effect resulted from the strengthening of the Canadian dollar against the U.S. dollar. Sales volume declined largely due to a 14 percent decrease in laundry and cleaning products sales volume, primarily attributable to nonrecurring business in the prior year and weaker demand. The lower laundry and cleaning sales volume was partially offset by growth in biodiesel, oil field chemicals and agricultural chemicals.

Net sales for European operations increased 35 percent due to a 34 percent increase in average selling prices and the favorable effects of foreign currency translation, which accounted for $58.0 million and $14.5 million, respectively of the net sales increase. Sales volume declined five percent between years, which reduced the year-over-year change by $9.7 million. The increase in average selling prices reflected higher raw material costs. The foreign currency translation effect resulted from the strengthening of the European euro and British pound sterling against the U.S. dollar. Weaker demand coupled with some lost business caused the sales volume decline.

Net sales for Latin American operations improved 31 percent as a result of a 15 percent increase in sales volume, the favorable effects of foreign currency translation and a seven percent increase in average selling prices, which accounted for $11.9 million, $7.0 million and $6.7 million, respectively, of the year-over-year net sales increase. Additional neutralizer business for the Company’s Brazil subsidiary accounted for the sales volume growth. The favorable currency translation impact resulted from the strengthening of the currencies for all three Latin American locations against the U.S. dollar. The increase in average selling prices was attributable to increased raw material costs.

The $33.6 million net sales increase for Asia operations reflected three quarters of sales for the Company’s Philippines subsidiary in 2011 compared to a partial quarter of sales in 2010.

Surfactants operating income for the first three quarters of 2011 was $1.3 million lower than operating income for the first three quarters of 2010. Gross profit increased $4.2 million due principally to the effects of improved margins in North America and the inclusion of the Philippines income in segment results. Lower Latin America gross profit, due largely to costs related to the start up of the neutralizer expansion in Brazil, negatively impacted surfactants gross profit. Operating expenses increased $5.5 million, or 10 percent. Year-over-year comparisons of gross profit by region and total segment operating expenses and operating income follow:

*(In thousands)*

| Gross Profit | For the Nine Months Ended September 30, 2011 | September 30, 2010 | Increase (Decrease) | Percent Change |
| --- | ---: | ---: | ---: | --- |
| North America | $107,859 | $100,151 | $7,708 | +8 |
| Europe | 16,825 | 19,156 | (2,331) | -12 |
| Latin America | 8,549 | 11,828 | (3,279) | -28 |
| Asia | 2,250 | 142 | 2,108 | NM |
| Total Surfactants Segment | $135,483 | $131,277 | $4,206 | +3 |
| Operating Expenses | 59,435 | 53,959 | 5,476 | +10 |
| Operating Income | $76,048 | $77,318 | $(1,270) | -2 |

Gross profit for North American operations improved eight percent year-over-year despite sales volume that declined six percent. A more favorable sales mix and the previously noted increase in average selling prices more than offset the impact of the decrease in sales volume. In addition, 2010 gross profit was negatively affected by expenses related to a one-month lockout of hourly workers at the Company’s Millsdale (Illinois) plant.

Gross profit for European operations declined 12 percent due to lower sales volume and higher manufacturing expenses. Manufacturing expenses were up about nine percent year-over-year primarily as a result of an increase in maintenance costs for the United Kingdom and Germany facilities. In addition, the effects of a planned three-week shutdown for a mandatory inspection at the Company’s Germany subsidiary contributed to the increase in manufacturing expenses. The favorable effects of foreign currency translation lessened the year-over-year decline in gross profit by $1.0 million.

Gross profit for Latin American operations declined 28 percent despite the 15 percent increase in sales volume. One-time costs related to a delay in the start up of the recent neutralizer capacity expansion project in Brazil and increased manufacturing costs attributable to the new neutralizing equipment more than offset the effect of the higher sales volume. In addition to the costs for Brazil, the decline in gross profit also reflected selling price increases that lagged raw material cost increases, particularly for the Mexico subsidiary. The favorable effects of foreign currency translation reduced the year-over-year decline in gross profit by $0.5 million.

The $2.1 million gross profit increase for Asia operations reflected three quarters of profit for the Company’s Philippines subsidiary in 2011 compared to a partial quarter of gross profit in 2010, when it was first consolidated after securing majority ownership.

Operating expenses for the surfactants segment increased $5.5 million, or 10 percent, year over year. Higher expenses for North American operations ($2.7 million), additional expenses for the Singapore and Philippines locations, which were first consolidated in the third quarter of

2010 ($1.6 million), and the effects of foreign currency translation ($1.3 million) accounted for most of the operating expense increase. The increase in North America operating expenses was attributable to higher marketing ($1.7 million) and research and development expenses ($1.1 million). Increased support expenses for the expanding Asia operations accounted for most of the increase in North American marketing expense. An increase in travel expense also contributed. Higher salary expense, along with an increase in temporary help, led to the rise in North America research and development expense.

#### Polymers

Polymers net sales for the first three quarters of 2011 increased $81.5 million, or 33 percent, over net sales for the same period of last year. Higher average selling prices, an 11 percent improvement in sales volume and the favorable effects of foreign currency translation accounted for $47.4 million, $26.4 million and $7.7 million, respectively, of the increase. A year-over-year comparison of net sales by region is displayed below:

*(In thousands)*

|  | For the Nine Months Ended September 30, 2011 | September 30, 2010 | Increase | Percent Change |
| --- | ---: | ---: | ---: | --- |
| North America | $202,594 | $161,570 | $41,024 | +25 |
| Europe | 104,739 | 70,471 | 34,268 | +49 |
| Asia and Other | 19,981 | 13,767 | 6,214 | +45 |
| Total Polymers Segment | $327,314 | $245,808 | $81,506 | +33 |

Net sales for North American operations increased 25 percent due to an 18 percent increase in average selling prices and a six percent increase in sales volume. The increases in average selling prices and sales volume accounted for $30.7 million and $10.3 million, respectively, of the net sales growth. The higher average selling prices reflected higher raw material costs for all polymer product lines. Sales volume for polyols increased 15 percent, while sales volume for phthalic anhydride declined four percent. The sales volume improvement for polyols resulted primarily from increased demand from existing rigid insulation board customers. Sales volume for phthalic anhydride customers was down due largely to weaker demand from polyester resin customers.

Net sales for European operations increased 49 percent due to an 18 percent rise in average selling prices, an 18 percent gain in sales volume and the favorable effects of foreign currency translation, which accounted for $14.7 million, $12.7 million and $6.9 million, respectively, of the net sales improvement. The higher average selling prices reflected higher year-over-year raw material costs. The increase in sales volume resulted from stronger demand from most major rigid insulation board customers and new demand for metal panel insulation and adhesive applications. In addition, the Company’s Poland subsidiary, which was acquired in the third quarter of 2010, accounted for 35 percent of the year-over-year sales volume growth.

Net sales for Asia and Other operations increased 45 percent between years due to a 26 percent increase in sales volume, an 11 percent increase in average selling prices and the favorable effects of foreign currency translation. New business for the China subsidiary led to the improvement in sales volume. Higher raw material costs led to the increase in average selling prices.

Polymer operating income for the first three quarters of 2011 improved $5.9 million, or 21 percent, over operating income for the same period of 2010. Gross profit increased $7.7 million, as all three regions posted gains. Operating expenses increased $1.8 million, or 13 percent. Below are year-over-year comparisons of gross profit by region and total segment operating expenses and operating income:

*(In thousands)*

| Gross Profit | For the Nine Months Ended September 30, 2011 | September 30, 2010 | Increase | Percent Change |
| --- | ---: | ---: | ---: | --- |
| North America | $36,383 | $30,980 | $5,403 | +17 |
| Europe | 10,847 | 9,237 | 1,610 | +17 |
| Asia and Other | 1,615 | 914 | 701 | +77 |
| Total Polymers Segment | $48,845 | $41,131 | $7,714 | +19 |
| Operating Expenses | 15,251 | 13,477 | 1,774 | +13 |
| Operating Income | $33,594 | $27,654 | $5,940 | +21 |

Gross profit for North American operations was up 17 percent due to improved unit margins and the 15 percent increase in polyols sales volume noted earlier. The previously mentioned selling price increases coupled with better raw material inventory positions, particularly for phthalic anhydride, pushed unit margins higher.

Gross profit for European operations increased 17 percent due to the aforementioned 18 percent growth in sales volume growth and $0.9 million in favorable foreign currency translation impact. The effects of higher year-over-year raw material costs coupled with the outsourcing of polyols from the segment’s North American operations due to capacity constraints partially offset the favorable impact of the sales volume growth. Polymers gross profit was adversely impacted by an estimated $2.2 million of higher costs of supplying polyols from the U.S. to Europe due to fire damage to one of the Company’s polyol reactors in Germany that occurred in the second quarter of this year. Repairs should be completed in November. Property insurance is expected to cover the repair costs. The potential benefit of any recovery under business interruption insurance will not be recorded until a settlement is recovered. Gross profit was also negatively affected by higher maintenance costs resulting from a planned shutdown at the Germany plant that is required every five years.

Gross profit for Asia and Other operations increased 77 percent due to selling price increases that recovered margin previously lost to increasing raw material costs and to the 26 percent growth in sales volume.

Operating expenses increased $1.8 million year-over-year due primarily to higher expenses for European operations ($1.6 million). Expenses for the Poland subsidiary, acquired in the third quarter of last year, contributed $0.8 million of the expense. Higher marketing expenses, attributable to increased salary, fringe benefits and travel expenses, accounted for the remainder of the increase in operating expenses for European operations.

#### Specialty Products

Net sales for the first three quarters of 2011 increased $7.5 million, or 22 percent, over net sales for the first three quarters of 2010. Higher sales volume of food ingredient products accounted for most of the segment’s increase in sales volume. Sales volume related to the new Lipid Nutrition product lines also contributed. Operating income was down $1.9 million, or 16 percent, between years due primarily to higher food ingredient raw material costs, for which competitive pressures have made it difficult to raise selling prices.

#### Corporate Expenses

Corporate expenses of $22.6 million for the first three quarters of 2011 were unchanged from corporate expenses reported for the same period of 2011. Deferred compensation income increased $2.2 million year-over-year, but was completely offset by increases in other expenses, most notably a $1.2 million increase in legal and environmental expenses and $0.5 million of higher expense related to derivative income reported in 2010 arising from recording certain electric contracts at fair value (the Company held no such contracts during 2011). With respect to deferred compensation, the Company recorded $2.7 million of deferred compensation income for the first three quarters of 2011 compared to $0.5 million of income for the first three quarters of 2010. Declines in the values of Company stock and the mutual fund assets to which the deferred compensation obligations are tied led to the higher year-over-year deferred compensation income. The value of Company common stock declined $9.09 per share from $76.27 per share at December 31, 2010, to $67.18 per share at September 30, 2011. For the first three quarters of last year, the Company’s common stock price declined $5.70 per share from $64.81 per share at December 31, 2009, to $59.11 per share at September 30, 2010. The increase in legal and environmental expenses reflected favorable remediation liability adjustments made in 2010 for two sites that did not recur in 2011.

#### LIQUIDITY AND CAPITAL RESOURCES

For the nine months ended September 30, 2011, the Company used $78.8 million of available cash plus $5.0 million of net borrowings and operating cash sources of $12.6 million to fund net investing cash outflows of $76.4 million and non-debt financing cash outflows of $18.8 million, with exchange rates decreasing cash by $1.1 million. For the current year to date, net income was up by $2.1 million and working capital consumed $41.0 million more than for the comparable period last year. Investing cash outflows increased by $0.4 million year over year. Cash flows used in financing activities were $13.8 million for the current year to date versus a $42.3 million cash source for the comparable period in 2010.

For the current year to date, changes in accounts receivable were a cash use of $92.7 million versus a use of $53.8 million for the comparable prior year period. Inventories were a use of $38.1 million in 2011 versus a use of $21.1 million in 2010. Accounts payable and accrued liabilities were a source of $53.0 million in 2011 compared to a source of $33.3 million in 2010.

During 2011, the rising cost of raw materials has been a key driver to higher working capital and the Company’s overall cash flow. The Company’s working capital investment is heavily influenced by the cost of crude oil and natural oils, from which many of its raw materials are derived. Higher raw material costs translate directly to higher inventory carrying costs and indirectly to customer selling prices and accounts receivable.

The year-to-date accounts receivable increase was the result of higher current quarter-end sales, mainly for the final two months of the current year quarter, over the fourth quarter of 2010, driven by both higher sales volume and higher selling prices. Accounts receivable turnover did not change significantly between December 31, 2010 and September 30, 2011. For inventories, somewhat less than 50 percent of the year-to-date inventory increase resulted from higher raw material costs with the rest attributable to planned increases in quantity to support improved customer service levels. The Company has not changed its own payment practices related to its payables. It is management’s opinion that the Company’s liquidity is sufficient to provide for potential increases in working capital during the remainder of 2011.

Investing cash outflows for the first nine months 2011 totaled $76.4 million versus $76.8 million for the comparable prior year period. Capital spending for the current year period totaled $61.0 million, including increased expenditures for capacity expansion, compared to $54.9 million for the comparable prior year period. Current year investing outflows included $13.6 million for the purchase of certain product lines of Lipid Nutrition B.V., a part of Loders Croklaan B.V. The purchase price included $5.0 million of inventory. During 2011 the Company also liquidated $1.6 million of investments for benefit plan participant payouts versus $0.8 million in 2010.

For the entire year of 2011, the Company estimates that capital spending will range from $85 million to $90 million including a capacity expansion in Singapore. The estimated range of capital expenditures excludes $12.2 million for the purchase of the Millsdale (Joliet), Illinois, warehouse, which was reflected in financing activities during the first quarter of 2011. Prior to the cash purchase, the warehouse was recorded as an asset on the Company’s balance sheet along with a build-to-suit lease obligation.

The Company purchases its common shares in the open market from time to time to fund its own benefit plans and also to mitigate the dilutive effect of new shares issued under its benefit plans. The Company may also make open market repurchases as cash flows permit when, in management’s opinion, the Company’s shares are undervalued in the market. For the first nine months of 2011, the Company purchased 20,157 common shares in the open market at a total cost of $1.3 million. As of September 30, 2011, there were 213,915 shares remaining under the current share repurchase authorization.

As of September 30, 2011, the Company’s cash and cash equivalents totaled $32.4 million, including $14.1 million in U.S. demand deposits and cash of the Company’s non-U.S. subsidiaries of $18.3 million.

Total Company debt decreased by $5.0 million for the current year to date, from $191.6 million to $186.6 million, with U.S. debt decreasing $9.9 million and foreign debt increasing $4.9 million. Higher foreign debt was driven primarily by capital spending in Europe. The decrease in U.S. debt reflected the liquidation of the previously noted build-to-suit lease obligation and an increase in revolving bank debt. Net debt (which is defined as total debt minus cash) increased by $73.8 million for the first nine months of 2011, from $80.4 million to $154.2 million. As of September 30, 2011, the ratio of total debt to total debt plus shareholders’ equity was 31.8 percent versus 35.2 percent at December 31, 2010. The ratio of net debt to net debt plus shareholders’ equity was 27.8 percent at September 30, 2011, compared to 18.5 percent at December 31, 2010.

As of September 30, 2011, the Company’s debt included $99.9 million of unsecured private placement loans with maturities extending from 2011 through 2022. These loans are the Company’s primary source of long-term debt financing and are supplemented by bank credit facilities to meet short and medium-term needs. The Company’s debt also included a $25.5 million term loan with its U.S. banks, which has maturities in 2012 and 2013.

The Company maintains a committed $60.0 million revolving credit agreement with three U.S. banks. This unsecured facility is the Company’s primary source of short-term borrowings and is committed through August 27, 2013 with terms and conditions that are substantially equivalent to those of the Company’s other U.S. loan agreements. At September 30, 2011, the Company had borrowings of $10.0 million and outstanding letters of credit of $2.6 million under this agreement, with $47.4 million remaining available. The Company anticipates that cash from operations, committed credit facilities and cash on hand will be sufficient to fund anticipated capital expenditures, working capital, dividends and other planned financial commitments for the foreseeable future.

Certain foreign subsidiaries of the Company maintain term loans and short-term bank lines of credit in their respective local currencies to meet working capital requirements as well as to fund capital expenditure programs and acquisitions. At September 30, 2011, the Company’s European subsidiaries had bank term loans of $5.4 million with maturities through 2015 and short-term bank debt of $23.2 million with available short-term borrowing capacity of $20.3 million. The Company’s Latin American subsidiaries had no outstanding debt, with $10.6 million of short-term borrowing capacity as of that date. As of September 30, 2011, the Company’s Singapore subsidiary was obligated for $14.3 million under an asset purchase agreement that took effect on November 4, 2010. The Company’s majority-owned joint ventures in the Philippines and China had debt totaling $8.4 million and available borrowing capacity of $8.8 million. The Company has guaranteed the debt obligations of its Singapore subsidiary and of its majority-owned joint ventures in the Philippines and China.

The Company has material debt agreements that require the maintenance of minimum interest coverage and minimum net worth. These agreements also limit the incurrence of additional debt as well as the payment of dividends and repurchase of treasury shares. Testing for these agreements is based on the combined financial statements of the U.S. operations of Stepan Company, Stepan Canada Inc., Stepan Specialty Products, LLC, Stepan Specialty Products B.V. and Stepan Asia Pte. Ltd. (the “Restricted Group”). Under the most restrictive of these debt covenants:

1\. The Restricted Group must maintain a minimum interest coverage ratio, as defined within the agreements, of 2.0 to 1.0, for the preceding four calendar quarters.

2\. The Restricted Group must maintain net worth of at least $175.0 million.

3\. The Restricted Group must maintain a ratio of long-term debt to total capitalization, as defined in the agreements, not to exceed 55 percent.

4\. The Restricted Group may pay dividends and purchase treasury shares in amounts of up to $30.0 million plus 100 percent of net income and cash proceeds of stock option exercises, measured cumulatively after December 31, 2001. The maximum amount of dividends that could have been paid within this limitation is disclosed as unrestricted retained earnings in Note 13, Debt, in the Notes to Consolidated Financial Statements.

The Company was in compliance with all of its loan agreements as of September 30, 2011. Based on current projections, the Company believes it will be in compliance with its loan agreements throughout 2011.

#### ENVIRONMENTAL AND LEGAL MATTERS

The Company is subject to extensive federal, state and local environmental laws and regulations. Although the Company’s environmental policies and practices are designed to ensure compliance with these laws and regulations, future developments and increasingly stringent environmental regulation could require the Company to make additional unforeseen environmental expenditures. The Company will continue to invest in the equipment and facilities necessary to comply with existing and future regulations. During the first nine months of 2011, the Company’s expenditures for capital projects related to the environment were $1.0 million. These projects are capitalized and depreciated over their estimated useful lives, which is typically 10 years. Recurring costs associated with the operation and maintenance of facilities for waste treatment and disposal and managing environmental compliance in ongoing operations at the Company’s manufacturing locations were $12.2 million and $11.6 million for the nine months ended September 30, 2011 and 2010, respectively. While difficult to project, it is not anticipated that these recurring expenses will increase significantly in the future.

Over the years, the Company has received requests for information related to or has been named by the government as a potentially responsible party at a number of waste disposal sites where cleanup costs have been or may be incurred under CERCLA and similar state statutes. In addition, damages are being claimed against the Company in general liability actions for alleged personal injury or property damage in the case of some disposal and plant sites. The Company believes that it has made adequate provisions for the costs it may incur with respect to the sites. It is the Company’s accounting policy to record liabilities when environmental assessments and/or remedial efforts are probable and the cost or range of possible costs can be reasonably estimated. When no amount within the range is a better estimate than any other amount, the minimum is accrued. Some of the factors on which the Company bases its estimates include information provided by feasibility studies, potentially responsible party negotiations and the development of remedial action plans. After partial remediation payments at certain sites, the Company has estimated a range of possible environmental and legal losses of $9.4 million to $29.2 million at September 30, 2011, compared to $10.0 million to $29.7 million at December 31, 2010. At September 30, 2011 and December 31, 2010, the Company’s accrued liability for such losses, which represented the Company’s best estimate within the estimated range of possible environmental and legal losses, was $15.2 million and $15.9 million, respectively. Actual costs could differ from the estimated reported liability. During the first nine months of 2011, cash outlays related to legal and environmental matters approximated $3.3 million compared to $2.1 million for the first nine months of 2010. Remediation of the soil at the Poland subsidiary accounted for most of the year-over-year change (see the Poland Manufacturing Site discussion in Note 8 to the condensed consolidated financial statements).

For certain sites, estimates of the total costs of compliance or the Company’s share of such costs cannot be determined; consequently, the Company is unable to predict the effect thereof on the Company’s financial position, cash flows and results of operations. Management believes that in the event of one or more adverse determinations in any annual or interim period, the impact on the Company’s cash flows and results of operations for those periods could be material. However, based upon the Company’s present belief as to its relative involvement at these sites, other viable entities’ responsibilities for cleanup and the extended period over which any costs would be incurred, the Company believes that these matters, individually and in the aggregate, will not have a material effect on the Company’s financial position. Certain of these matters are discussed in Item 1, Part 2, Legal Proceedings, in this report and in other filings of the Company with the Securities and Exchange Commission, which are available upon request from the Company. See also Note 8 to the condensed consolidated financial statements for a summary of the environmental proceedings related to certain environmental sites.

#### OUTLOOK

The Company’s growth initiatives remain on track to deliver increased earnings in 2012. Management expects surfactants earnings to improve in 2011 as growth from the Company’s higher margin functional surfactants offsets the weakness in consumer volumes. Surfactant demand for enhanced oil recovery continues to grow. The Brazil expansion is complete and delivered improved results in the third quarter. The recent fall of commodity prices should improve margins in the fourth quarter.

Global polyols volume continues to benefit from recommendations to use higher insulation levels to reduce energy consumption and new applications. The polyol supply chain cost should decrease in 2012 as the Company begins to utilize its expanded capacity in Germany. Specialty products earnings are expected to benefit from the Lipid Nutrition product line acquisition.

In 2011 the Company has the opportunity to achieve its fourth consecutive record income year despite the economy and higher expenses associated with growth initiatives in Brazil, Singapore, Poland and the Netherlands.

#### CRITICAL ACCOUNTING POLICIES

There have been no material changes to the critical accounting policies disclosed in the Company’s 2010 Annual Report on Form 10-K.

## Controls and procedures

As filed, 733 characters.

a. Evaluation of Disclosure Controls and Procedures

Based on their evaluation of our disclosure controls and procedures as of the end of the most recent fiscal quarter covered by this Form 10-Q, our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) promulgated under the Securities Exchange Act of 1934) were effective as of September 30, 2011.

b. Changes in Internal Control Over Financial Reporting

There were no changes in internal controls that occurred during our most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Filed Oct 28, 2011.
Source: SEC EDGAR, the filing index for accession 0001193125-11-286131. Last ingested by Listed: Nov 10, 2026, 21:16 ET. No prices; not investment advice.
